Evidence map›Paper›PMID 33021057›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2021

T cell repertoire analysis suggests a prominent bystander response in human cardiac allograft vasculopathy.

Marlena V Habal, April M I Miller, Samhita Rao, Sijie Lin, Aleksandar Obradovic, Mohsen Khosravi-Maharlooei, Sarah B See, Poulomi Roy, Ronzon Shihab, Siu-Hong Ho and 12 more

Open access · hybridAbstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Proinflammatory and cytotoxic CD38American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Article
  3. Article
  4. Review
  5. Immunosuppression Management in Heart Transplantation.Methodist DeBakey cardiovascular journal · 2025
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 1 country.

Marlena V HabalColumbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, New York.ORCID 0000-0001-8217-9822
April M I MillerColumbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, New York.
Samhita RaoColumbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, New York.
Sijie LinColumbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, New York.
Aleksandar ObradovicColumbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, New York.
Mohsen Khosravi-MaharlooeiColumbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, New York.
Sarah B SeeColumbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, New York.ORCID 0000-0002-4208-317X
Poulomi RoyColumbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, New York.
Ronzon ShihabColumbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, New York.
Siu-Hong HoColumbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, New York.
Charles C MarboeDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York.
Yoshifumi NakaDepartment of Surgery, Division of Cardiothoracic Surgery, Columbia University Irving Medical Center, New York, New York.
Koji TakedaDepartment of Surgery, Division of Cardiothoracic Surgery, Columbia University Irving Medical Center, New York, New York.
Susan RestainoDepartment of Medicine, Division of Cardiology, Columbia University Irving Medical Center, New York, New York.
Arnold HanColumbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, New York.
Donna ManciniDepartment of Medicine, Mount Sinai Hospital, Icahn School of Medicine, New York, New York.
Michael GivertzDepartment of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Joren C MadsenCenter for Transplantation Science, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Megan SykesColumbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, New York.ORCID 0000-0002-4947-4376
Linda J AddonizioDepartment of Pediatrics, Division of Pediatric Cardiology, Columbia University Irving Medical Center, New York, New York.
Maryjane A FarrDepartment of Medicine, Division of Cardiology, Columbia University Irving Medical Center, New York, New York.
Emmanuel ZornColumbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, New York.ORCID 0000-0001-9985-8389
Columbia University Irving Medical Center · USBrigham and Women's Hospital · USHarvard University · USMount Sinai Hospital · US

Funding

Contribution of B cells to human cardiac allograft vasculopathyR01AI116814 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ZORN, EMMANUEL · 2015 to 2019
$1.8M
Becton Dickinson LSR II Analytical Flow CytometerS10RR027050 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CLYNES, RAPHAEL A. · 2011 to 2011
$413k
National Institute of Allergy and Infectious Diseases R01-AI116814NCRR NIH HHS S10 RR027050NIAID NIH HHS R01 AI116814
6 · The paper itself

Abstract

T cells are implicated in the pathogenesis of cardiac allograft vasculopathy (CAV), yet their clonality, specificity, and function are incompletely defined. Here we used T cell receptor β chain (TCRB) sequencing to study the T cell repertoire in the coronary artery, endomyocardium, and peripheral blood at the time of retransplant in four cases of CAV and compared it to the immunoglobulin heavy chain variable region (IGHV) repertoire from the same samples. High-dimensional flow cytometry coupled with single-cell PCR was also used to define the T cell phenotype. Extensive overlap was observed between intragraft and blood TCRBs in all cases, a finding supported by robust quantitative diversity metrics. In contrast, blood and graft IGHV repertoires from the same samples showed minimal overlap. Coronary infiltrates included CD4

Indexed as

Heart TransplantationAllograftsCoronary VesselsGraft RejectionHumansT-Lymphocytesbasic (laboratory) research/sciencecoronary artery diseaseheart (allograft) function/dysfunctionheart transplantation/cardiologymolecular biologyrejection: vascularT cell biology

Identifiers

PMID33021057
PMCPMC8672660
OpenAlexW3090877279

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.